In addition, our findings provide important insights into the mechanism by which RFWD2 and RCHY1 collaborate to negatively regulate P27 stability, indicating that blocking the RFWD2-RCHY1 signaling axis is a feasible strategy with reduced P27 to potentiate PIs therapy for combating MM. The gene discussed is RCHY1; the disease is Miyoshi myopathy.